Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: Post-hoc analysis of concomitant add-on versus sequential add-on to metformin and of triple versus dual therapy with metformin
A clinical trial from Spain treated adults, with an average age of 74, for eight weeks with 1,000 g of cyanocobalamin per day and then for another 46 weeks with 1,000 g per week
Originally researched for neurodegenerative conditions, Tesofensine demonstrated a profound impact on body weight and fat mass during clinical trials
Further innovation is seen in triple agonists such as retatrutide, which targets GIP, GLP-1, and glucagon receptors to amplify metabolic effects
Long-term compliance with anti-doping protocols depends on educational initiatives, systematic testing procedures, and independent oversight processes rooted in the WADA Prohibited List